# A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer

> **NCT00156884** · PHASE2 · COMPLETED · sponsor: **Alberta Health services** · enrollment: 58 (estimated)

## Conditions studied

- Hormone Refractory Prostate Cancer
- Bone Metastases

## Interventions

- **DRUG:** strontium-89
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT00156884
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2012-01-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00156884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00156884, "A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00156884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*